AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2019

Nov 25, 2019

30071_dirs_2019-11-25_41cb2f88-6f27-4e73-8af6-814a28d69629.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-11-21

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-21	ResMed Common Stock	A	1727	—	Acquired	228028	Direct

Footnotes

F1: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2020, or the annual shareholders meeting in the year following the grant date.